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We have used the polymerase chain reaction technique (PCR) to clone the cDNA of the D2 dopamine receptor from rat striatal mRNA. Two 
major PCR products were produced; one product was identical to a previously published rat cDNA, while the other, more abundant product dif- 
fered only by an 87nucleotide insert located in the region of the putative third cytoplasmic loop of the D, receptor. A PCR approach for determin- 
ing message abundance was used to determine the relative message abundance of the two forms of the Dz receptor in a variety of tissues. Possible 
implications of the two forms of the D2 receptor for dopamine-mediated signal transduction are discussed. 
D, dopamine receptor subtype; G-protein coupled receptor; Polymerase chain reaction 
1. INTRODUCTION 
Dopamine receptors have been classified into Dr and 
DZ subtypes [l] and the cDNA of a rat dopamine D2 
receptor has been cloned, sequenced and expressed by 
Civelli and colleagues and shown to be a member of the 
family of G-protein-linked receptors [2]. To establish 
our own cell line expressing this dopamine D2 receptor, 
we designed oligonucleotide primers based on the 
published nucleotide sequence [2] in order to amplify 
rat striatal cDNA for the DZ receptor by the polymerase 
chain reaction (PCR) method [3]. By using PCR, we 
could circumvent cDNA library construction and 
screening and perhaps amplify other potentially in- 
teresting cDNAs which might share homology for the 
oligonucleotide primers. 
We now report that our PCR amplification of the rat 
striatal cDNA for the Dz receptor results in essentially 
two amplified products. These products differ only by 
a single 87-nucleotide insert and are otherwise identical 
to the published sequence of the rat D2 receptor. Addi- 
tionally, we detail our PCR strategy for detecting dif- 
ferences in the amplified products and for obtaining 
full-length sequences for the two forms of the D2 recep- 
tor. Finally, we present data on the relative abundance 
of the two forms in a variety of tissues. 
2. EXPERIMENTAL 
2.1. Cell lines 
COS-1 cells were obtained from ATCC and maintained in Dulbec- 
co’s Modified Eagles Medium (Sigma) containing 10% fetal calf 
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serum (Sigma) and 1 x antibiotic/antimycotic solution (Sigma) at 
37°C and 95% air/Y/o COr. MMQ cells cloned from the rat 7315a 
anterior pituitary tumor [4] were obtained from Dr Robert MacLeod 
of the U.Va. and maintained in RPM1 1640 containing 2.4% fetal 
calf serum (Hyclone), 7.3% horse serum (Irvine Scientific), 2 mM 
glutamine, 1 x antibiotic/antimycotic and 18 fig/ml gentamicin at 
37°C and 95% sir/5% COZ. 
2.2. Tissue dissection 
Rats were killed by decapitation and the brains, pituitary glands, 
and livers were removed and dissected on ice. Striata, substantia 
nigra and cerebellum were dissected from each brain. The anterior 
pituitary and intermediate lobe were dissected from each pituitary. 
All tissues were frozen on dry-ice or liquid nitrogen immediately 
upon dissection and then stored at -70°C. 
2.3. RNA extraction 
RNA was prepared from cells or tissues by the RNAzol method 
(Cinna/Biotecx) in which cells or tissues were homogenized in 
RNAzol solution (2 ml/100 mg tissue or lo7 cells) containing 
guanidinium thiocyanate, phenol and 2-mercaptoethanol and the 
RNA extracted following addition of chloroform and centrifugation. 
The aqueous phase was removed and the RNA precipitated by 
isopropanol at -20°C. The RNA yield was approximately 1 mg/g 
tissue. 
2.4. Oligonucleotides 
Oligonucleotides were synthesized by the Corporate Molecular 
Biology Group of Abbott Laboratories using the ,&cyanoethyl 
phosphoramidite method on Applied Biosystems models 380A and 
380B DNA synthesizers. The sequences of the individual primers 
were as follows: 
Primer A: CCGTGCGTGGATGCGGCGGGAGCTGGC 
Primer B: GCATCTCCATTTCCAGCTCCTGAGCTCGG 
Primer C: CCGAGCTCAGGAGCTGGAAATGGAGATGC 
Primer D: CCTGCAGGGTCGAGAGAAGGCCAAG 
Primer E: AATCTACATCGTCCTCCGGAAGCGCC 
Primer F: TGGGATGGATCAGGGAGAGTGAGCTG 
Probe 1: same as Primer C above 
Probe 2: GGCAACTGTACCCACCCTGAG 
2.5. cDNA synthesis 
l-10 pg of total cellular RNA were co-precipitated with 10 fig of 
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yeast tRNA as carrier and resuspended in ddHz0. The RNA was 
primed with DZ receptor-specific antisense primer and the synthetic 
reaction was done in a final volume of 25 81 using the components 
and conditions specified by the manufacturer (BRL) with the excep- 
tion that Seikagaku avian myeloblastosis virus reverse transcriptase 
was used. After incubation at 37°C for 1 h, an equal volume of 3 M 
Na-acetate was added, followed by 4 vols of EtOH for precipitation. 
2.6. DNA amplification 
Oligonucleotide primer sets A-B and C-D were designed to 
amplify two contiguous stretches of the cDNA which, together, en- 
compassed the entire coding region> well as some non-coding region 
at the 5 ’ - and 3 ‘-ends (see Fig. 1A). Primer set A-D was used to 
amplify the full-length cDNA of the D2 receptor. All reagents and the 
Taq DNA polymerase for the amplification reaction were purchased 
from Perkin Elmer Cetus. The reaction was performed for 30 cycles; 
each cycle consisting of 2 min at 94°C and 6 min at 72”C, using a 
DNA thermal cycler (Perkin Elmer &us). Aliquots of amplified 
product were either run on agarose gels or subcloned into plasmid 
vectors. 
2.7. Cloning and sequencing of the full-length cDNA 
Amplified product from the primer set C-D was digested at SmaI 
and PstI sites (see Fig. 1A) and subcloned into a similarly designed 
pUC18 vector. E. co/i strain JM109 were transformed by the pUCl8 
constructs for plasmid amplification and clear plaques were picked 
and grown as separate clones. Plasmid DNA from each bacterial 
clone was purified by the CsCl technique [5]. Clones bearing the long 
form of the DZ receptor cDNA were identified by restriction digest 
analysis. The cDNA of the long form of the DZ receptor was then se- 
quenced from the identified CsCl-purified plasmids using the Se- 
quenase method (United States Biochemicals). Sequencing 
oligonucleotides were designed to be 150 bp apart. The sequencing 
reaction and gel were run according to the supplier’s protocol. 
2.8. Identification and quantitation of PCR products 
Starting with rat striatal RNA, cDNA synthesis and amplification 
were performed as described above using the primer set E-F. The 
PCR reaction was allowed to run for either 10 or 30 amplification 
cycles and the products run on a 1.5% agarose gel. The resolved pro- 
ducts were transferred by capillary action to Zeta-probe membranes 
(Bio-Rad) for hybridization to oligonucleotide probes labelled at the 
5’-end with “P using bacteriophage T4 polynucleotide kinase. The 
transfer, hybridization and washing of the membranes were done ac- 
cording to the Bio-Rad protocol. The hybridization probes were Pro- 
bes 1 and 2 of section 2.4 above. The washed membranes were dried, 
and autoradiographed. The bands on the autoradiograms were first 
quantified using an LKB Ultroscan XL laser densitometer and then 
used to locate the corresponding bands on the membranes which were 
cut out and placed in vials containing liquid scintillation fluid for 
quantification by liquid scintillation spectroscopy. 
3. RESULTS AND DISCUSSION 
The PCR product from the primer set C-D (Fig. 1A) 
ran on an agarose gel as a single band of predicted size 
whereas the product from primer set A-B (Fig. 1A) ran 
as two distinct bands. The lower band was of the 
predicted size; the upper band was more abundant 
(Fig. 1B). The Dz receptor cDNA has a unique BumHI 
site adjacent to the initiation ATG codon. When cut 
with BarnHI, both bands from this primer set were 
reduced to the same extent (Fig. lB), suggesting se- 
quence homology between the products beyond that for 
the common priming regions. The sequence for the 
long form (see Fig. 2) was found to be identical to that 
+---s7zb.P.+632b.p._--_l 
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Fig. 1. PCR amplification of the rat D2 receptor cDNA. (A) 
Schematic for the PCR amplification showing locations of the primer 
sets A-B, C-D and A-D. (B) Ethidium bromide stained agarose 
gels: lanes 1 and 4, size markers; lane 2, tRNA control; lane 3, PCR 
product of the C-D primer set; lane 5, PCR products of the A-B 
primer set; lane 6, PCR products of the A-B primer set cut with 
EamHI (note the non-specific bands are not cut by BarnHI). 
of the previously published sequence for the cDNA of 
the rat Dz receptor [2] except for the presence of an 
87-bp insert. The Dz receptor, like other G-protein- 
coupled receptors, is thought to be an integral mem- 
brane protein of 7 transmembrane spanning regions 
which connect an N-terminal extracellular head to a 
COOH-terminal cytoplasmic tail and the 87-nucleotide 
insert is within the region coding for the putative third 
cytoplasmic loop of the receptor [6]. Within the insert 
there are 2 consensus sites for N-glycosylation and 2 
cysteines which could form a disulfide bridge or serve 
as sites for lipid modification. 
To determine the relative abundance of the two 
forms of the Dz receptor, the primer set E-F was used 
to amplify, by PCR, the cDNAs reverse transcribed 
from mRNA for the short or long forms of the receptor 
(Fig. 3A). Total RNA from a variety of tissues was us- 
ed for the cDNA synthesis. The primer set E-F was 
designed so that amplified product originating from 
mRNA for the short form would be 215 bp while pro- 
duct from the message ncoding the 87-bp insert would 
19 
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10 30 50 
GCTGCCGGAGGGGCGGCCGTGCGTGGATGCGGCGGGAGCTGGMGCCTCCAGCAGCCGGC 
70 90 110 
GCCTTCTCTGGCCCCGGGCGCCATATGGCTTCAAGAGCCG 
130 150 170 
GCCCCMTGGATCCACTGMCCTGTCCTGGTACGATGACGATCTGGAGAGGCAGMCTGG 
HetAspProLeuAsnLeuSerTrpTyrAspAspAspLeuGluArgGlnAsnTrp 
190 210 230 
AGCCGGCCCTTCMTGGGTCAGMGGGMGGCAGACAGGCCCCA~ACMCTACTATGCC 
SerArgProPheAsnGlySerGluGlyLysAlaAspArgProHisTyrAsnTyrTyrAla 
250 270 290 
ATGCTGCTCACCCTCCTCATCTTTATCATCGTCTTTGGCAATGTGCTGGTGTGCATGGCT 
HetLeuLeuThrLeuLeuIlePheIleIleValPheGlyAsnValLeuValCysMetAla 
- 310 330 350 
GTATCCCGAGAGMGGCTTTGCAGACCACCACCM~ACTTGATAGTCAGCC~G~GTG 
ValSerArgGluLysAlaLeuGlnThrThrThrAsnTyrLeuIleValSerLeuAlaVal 
370 390 410 
GCTGATCTTCTGGTGGCCACA~GGTMTGCCGTGGGTTGTGGTGGGT 
AlaAspLeuLeuValAlaThrLeuVal~etProTrpValValTyrLeuGluValValGly 
430 450 470 
GATTGGAMTTCAGCAGGATTCA~GTGACATCmGTCACGTGC 
AspTrpLysPheSerArgIleHisCysAspIlePheValThrLeuAspValMetHetCys 
490 510 530 
ACAGCMGCATCCTGMCCTGTGTGCCATCAGCATCAGCATTGACA~TACACAGCTGTGGCMTG 
ThrAlaSerIleLeuAsnLeuCysAlaIleSerIleAspArgTyrThrAlaValAlaMet 
550 570 590 
CCCATGCTGTATMCACACGCTACAGCFCCAAGCGCCGAGT 
ProHetLeuTyrAsnThrArgTyrSerSerLysArgArgValThrValMetIleAlaIle 
610 630 650 
GTCTGGGTCCTGTCCTTCACCATCTCCTGCCCACTGCTCTACAGAC 
ValTrpValLeuSerPheThrIleSerCysProLeuLeuPheArgLeuAsnAsnThrAsp 
670 690 710 
CAGGGTGAGTGTATCATTGCCMCCCTGCCTTTGTCCTCTTC 
GlnGlyGluCysIleIleAlaAsnProAlaPheValValTyrSerSerIleValSerPhe 
730 750 770 
TACGTGCCCTTCATCGTCACTCTGCTGGTCTATATATC~T~ACATCGTC~CCGGMG 
TyrValProPheIleValThrLeuLeuValTyrIleLysIleTyrIleValLeuArgLys 
790 810 830 
CGCCGGMGCGGGTCAACACCAAGCGCAGCAGTffiAGcTTl’CAGAGCCMCCTGAAGACA 
ArgArgLysArgValAsnThrLysArgSerSerArgAlaPheArgAlaAsnLeuLysThr 
850 870 890 
CMCTGTACCCACCCTGAGGACATGMAcTcTGCACCGTTATCATGMG’ 
&nCysThrHisProCluAspHetLysLeuCyThrValIleHetLys 
910 930 950 
TCTAATGGGAGTTTCCCAGTGMCAGGCGGAGAAT TGCTGCCCGCCGAGCTCAGGAG 
Ser~GlySerPheProValAsnArgArgArgHe SpAlaAlaArgArgAlaGlnGlu 
970 990 1010 
CTGGAAATGGAGATGCTGTCAAGCACCAGCACCAGCCCCCCAGAGAGGACCC~TATAGCCCCATC 
LeuGluHetGluMetLeuSerSerThrSerProProGluArgThrArgTyrSerProIle 
1030 1050 1070 
CCTCCCAGTCACCACCAGCTCACTCTCCCTGATCCATCCCACCAC~C~ACATAGCAAC 
ProProSerHisHisGlnLeuThrLeuProAspProSerHisHisGlyLeuHisSerAsn 
1090 1110 1130 
CCTGACAGTCCTGCCAAACCAGAGMGMTGGGCACGCCA~CCMGATTGTCMTCCCAGGA~ 
ProAspSerProAlaLysProGluLysAsnGlyHisAlaLysIleValAsnProArgIle 
1150 1170 1190 
GCCAAGTTCTTTGAGATCCAGACCATGCCCMTGGCAAAAGACG 
AlaLysPhePheGluIleGlnThrHetProAsnGlyLysThrArgThrSerLeuLysThr 
1210 1230 1250 
ATGAGCCGCAGAMGCTCTCCCAGCAGM~AGMG~GCCA~CAGATGCTTGCCATT 
MetSerArgArgLysLeuSerGlnGlnLysGluLysLysAlaThrGlnHetLeuAlaIle 
1270 1290 1310 
GTT~T~GGTGTG~~AT~AT~G~GG~TG~~~~TT~AT~A~~A~AT~~TGMTATA 
ValLeuGlyValPheIleIleCysTrpLeuProPhePheIleThrHisIleLeuAsnIle 
1330 1350 1370 
CACTGTGATTG~M~AT~~~A~~AGT~~TCTA~AG~~~~CA~ATGG~GGGCTATGTC 
HisCysAspCysAsnIleProProValLeuTyrSerAlaPheThrTrpLeuGlyTyrVal 
1390 1410 1430 
MCAGTGCCGTCMCCCCATCATCTACACACCAC~CMCATCGAG~CCGCMGGCCTTC 
AsnSerAlaValAsnProIleIleTyrThrThrPheAsnIleGluPheArgLysAlaPhe 
1450 1470 1490 
ATGAAGAT~~G~A~TG~TGAGT~G~~CCTTG~~TG~A~AG~AG~G~~CCACCTCC 
MetLysIleLeuHisCys 
1510 1530 1550 
CTGCCTATGCAGGCCAGACCTCATCCCTGCAACCTGTGGCCT 
1570 1590 
TGGCCTTCTCTCGACCCTGCAGGCCCTGCAGTGTTA 
Fig. 2. Nucleotide and amino acid sequences of the cDNA of the rat 
DZ dopamine receptor containing the 87-bp insert (boxed). Possible 
N-glycosylation sites and cysteines within the insert are underlined. 
be 302 bp (Fig. 3A). As an additional check that the 
PCR products represented cDNAs from the Ds recep- 
tor, products from one tissue, the rat striatum, 
were Southern blotted and hybridized to 
SM 
IL 
CER 
AP 
STR 
MMQ 
cos 
SN 
LIV 
SM 
Fig. 3. Tissue distribution of the short and long forms of the DZ 
receptor. (A) Schematic for PCR amplification of two discriminable 
cDNA products for the short and long forms of the Dz receptor. (B) 
Left panel: ethidium bromide stained agarose gel of size markers and 
PCR products; IL = rat intermediate lobe; CER = rat cerebellum; 
AP = rat anterior pituitary; STR = rat striatum; MMQ = MMQ cell 
line (rat-derived); COS = COS-1 cell line (monkey-derived); SN = rat 
substantia nigra; LIV = rat liver. 
[32P]oligonucleotide probes. Probe 1 was a 29-mer 
oligonucleotide starting 12 nucleotides 3 ’ to the insert 
and therefore common to the two forms of the receptor 
while Probe 2 was a 26-mer unique to the insert. As 
seen in Fig. 4, Probe 1 hybridized to the long and short 
PCR products while Probe 2 selectively hybridized to 
the long form. Moreover, the relative amounts of the 
two forms were the same following 10 or 30 cycles of 
PCR amplification. This demonstrates that the relative 
amounts of the PCR products most likely reflect the 
relative amounts of the original transcripts and not the 
preferential amplification of one of the cDNAs since 
the latter would alter the ratio of PCR products as 
amplification proceeded from 10 to 30 cycles. 
The main result is that the longer PCR product was 
clearly present and more abundant han the short form 
20 
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Fig. 4. Autoradiograms of Southern blots of rat striatal cDNA 
amplified for 10 or 30 PCR cycles using primer set E-F and 
hybridized to oligonucl~tide probes 1 or 2. Lane 1: 10 cycles, Probe 
I. Film exposed for 24 h. Long form represents 67% of Dz receptor 
cDNA as determined by laser densitometry. Lane 2: 30 cycles, Probe 
1. Film exposed for 30 min. Long form represents 71% of Dr 
receptor cDNA as determined by both laser densitometry and liquid 
scintillation spectroscopy. Lane 3: 30 cycles, Probe 2. Film exposed 
for 30 min. 
in every rat tissue studied (Fig. 3B). In striatum and 
substantia nigra, approximately 70% of Dz transcripts 
coded for the longer, insert-plus form (Fig. 4). In the 
liver and in pituitary tissues of anterior pituitary and in- 
termediate lobe, as well as in the pituitary-derived 
MMQ cells, the short form was either not detectable or 
barely present. In the cerebellum, which is not generally 
recognized as a Dz receptor-expressing tissue, both 
forms were faintly detected, and again, the PCR pro- 
duct for the long form predominated. The only excep- 
tion to the general pattern of relative abundance was 
found in the monkey-derived COS-1 cell in which the 
lower band product predominated and was a slightly 
smaller size. 
We included cerebellum, liver and COS-1 cells in our 
tissue distribution analysis to serve as negative controls, 
thinking these tissues to be negative for DZ receptor ex- 
pression. However, we have since learned that others 
have found evidence for DZ receptor transcripts in 
cerebellum using the slot-blot method and have verified 
these results by radioligand binding experiments using 
the new high-affinity D2 radioligand, [12?]epidepride 
(personal communication, K. Neve). We expect our 
results in liver to be similarly confirmed. The result 
from the COS-1 cells is more perplexing, since it was 
the only tissue where the shorter form predominated. 
However, the size of the shorter form was slightly 
smaller than predicted (see Fig. 3B) and we do not 
know whether this reflects a species difference in the Dz 
receptor (the COS-1 cell is derived from African green 
monkey kidney epithelium) or a product that is not a 
DZ receptor. 
The results of the present study indicate that two 
transcripts exist for the rat D2 dopamine receptor which 
differ only by the presence of an 87-bp insert. The com- 
plete identity of the two forms outside the insert suggest 
that they are alternatively spliced transcripts. Alter- 
native splicing is consistent with evidence of introns in 
the rat DZ receptor gene [2] despite the lack of introns 
in the majority of G-protein-coupled receptor genes se- 
quenced to date 171. 
What is the significance of the insert in the putative 
third cytoplasmic loop of the Dz receptor? Assuming 
that the receptor protein contains the insert, it is 
natural to focus on possible implications for signal 
transduction since this loop has been shown to be im- 
portant for signal transduction of (Y- and fl-adrenergic 
receptors and muscarinic acetylcholine receptors [8,9]. 
However, when the analysis has been narrowed to 
within the loop, the transducing regions appear to be 
restricted to the 5 ’ - and 3 ‘-ends of the loop which is in 
keeping with the location of the peripheral tr~sducing 
G-proteins at the cytoplasmic surface of the membrane 
[ 10,111. Since the insert is outside of these regions how 
could it influence DZ receptor signal transduction? One 
possibility is that the insert provides a site of membrane 
attachment hereby creating sub-loops within this large 
cytoplasmic loop. Recent work on the Ras proteins, for 
example, suggests that lipid modification of cysteines 
by palmitoylation or polyisoprenylation might play a 
role in anchoring the peripheral proteins to the plasma 
membrane [12,131 and a similar role for palmitoylation 
of adjacent cysteines has been proposed to create a 
fourth cytoplasmic loop of rhodopsin 1141;. In this 
regard it is interesting to note two adjacent cysteines in 
the third cytoplasmic loop of the Ml muscarinic 
acetylcholine receptor. Moreover, in the &-adrenergic 
receptor, the mutation of a carboxyl tail cysteine to pre- 
vent its palmitoylation results in the uncoupling of the 
receptor from activation of adenylate cyclase [ 151. Two 
cysteines (Cys-268 and Cys-277) are present in the 29 
amino acid insert of the Dz receptor and the latter is 
Part of a possible consensus sequence for 
polyisoprenylation [ 161. 
It is known that D:! receptor activation by dopamine 
leads to inhibition of adenylate cyclase, increased mem- 
brane potassium conductance, and inhibition of 
calcium currents 1171 and that Dz receptor purified 
from bovine anterior pituitary exhibits a selectivity for 
one of the G-proteins designated Gi2 [18]. Whether the 
87-bp, 29 amino acid insert directs the protein among 
these transduction pathways and whether the insert 
might work by altering G-protein affinity via the for- 
mation of cytoplasmic sub-loops are important issues 
to be resolved. 
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